Tempo Therapeutics, Inc.

About Tempo Therapeutics, Inc.

Tempo Therapeutics is pioneering a new era in tissue engineering biotechnology. Their mission is to harness the power of immunomodulation and material science through their proprietary MAP technology to transform medical technology and enable the future of medicine. They aim to build functional tissue and organs within patients to treat disease, improve outcomes, and save lives.

Products & Services

Biosurgery products for soft tissue reconstructions (for dermal and abdominal wall indications), improving tissue strength and restoring function by building new vascular tissue.

Combination drug delivery technologies based on MAP technology.

Allogenic cell engraftment solutions using MAP technology.

Novel therapies in various therapeutic areas using MAP technology.

Specialties

Tissue Engineering Immunomodulation Material Science Medical Technology Biosurgery Drug Delivery Cell Engraftment Vaccine Technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 12000000 MR: - FA: 12 million FAN: 12000000	D: 2024-03-19 FD: 2024-03-19	2 investors

Series A Latest

2024-03-19

$12.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Westbrook Weaver, PhD

Co-Founder, President, and Chief Executive Officer

D

Donald Griffin

Chief Science Officer

S

Stephanie Deshayes, PhD

VP R&D

K

Kwame Ulmer

Chief Regulatory Officer

S

Shelly Vandertie

SVP FINANCE

A

Andrea Quach

DIRECTOR OF CLINICAL OPERATIONS

View 13 more team members with Pro

Unlock Full Team Directory

Recent News